These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Efficacy and safety of cyclosporin A ophthalmic emulsion in the treatment of moderate-to-severe dry eye disease: a dose-ranging, randomized trial. The Cyclosporin A Phase 2 Study Group. Stevenson D; Tauber J; Reis BL Ophthalmology; 2000 May; 107(5):967-74. PubMed ID: 10811092 [TBL] [Abstract][Full Text] [Related]
71. Conjunctival and corneal pneumatic sensitivity is associated with signs and symptoms of ocular dryness. Situ P; Simpson TL; Fonn D; Jones LW Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):2971-6. PubMed ID: 18390645 [TBL] [Abstract][Full Text] [Related]
72. Corneal epithelial permeability of dry eyes before and after treatment with artificial tears. Göbbels M; Spitznas M Ophthalmology; 1992 Jun; 99(6):873-8. PubMed ID: 1630776 [TBL] [Abstract][Full Text] [Related]
73. The effect of recurrent povidone-iodine usage on conjunctival flora in diabetic patients undergoing intravitreal injections. Einan-Lifshitz A; Sorkin N; Smollan G; Barequet I Eur J Ophthalmol; 2021 Mar; 31(2):607-611. PubMed ID: 31983226 [TBL] [Abstract][Full Text] [Related]
74. A single LipiFlow® Thermal Pulsation System treatment improves meibomian gland function and reduces dry eye symptoms for 9 months. Greiner JV Curr Eye Res; 2012 Apr; 37(4):272-8. PubMed ID: 22324772 [TBL] [Abstract][Full Text] [Related]
75. Minimizing the endophthalmitis rate following intravitreal injections using 0.25% povidone-iodine irrigation and surgical mask. Shimada H; Hattori T; Mori R; Nakashizuka H; Fujita K; Yuzawa M Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1885-90. PubMed ID: 23389553 [TBL] [Abstract][Full Text] [Related]
76. Symptoms of ocular irritation in patients diagnosed with dry eye. Nichols KK; Begley CG; Caffery B; Jones LA Optom Vis Sci; 1999 Dec; 76(12):838-44. PubMed ID: 10612405 [TBL] [Abstract][Full Text] [Related]
77. Randomized Controlled Study of Cooled vs Room-Temperature Artificial Tears for Reducing Ocular Surface Irritation After Intravitreal Injection. Mani S; Jin HD; Shonka B; Fortenbach CR; Russell JF J Vitreoretin Dis; 2023; 7(4):310-315. PubMed ID: 37927318 [No Abstract] [Full Text] [Related]
78. A Multicenter, Randomized, Double-Blind Evaluation of the Efficacy of TJO-087 Versus 0.05% Cyclosporine A in Moderate to Severe Dry Eye. Eom Y; Yoon KC; Kim HK; Song JS; Hyon JY; Kim HM J Ocul Pharmacol Ther; 2023; 39(1):27-35. PubMed ID: 36450107 [No Abstract] [Full Text] [Related]
79. Comparison of topical cyclosporine, punctal occlusion, and a combination for the treatment of dry eye. Roberts CW; Carniglia PE; Brazzo BG Cornea; 2007 Aug; 26(7):805-9. PubMed ID: 17667613 [TBL] [Abstract][Full Text] [Related]
80. Effects of lubricating agents with different osmolalities on tear osmolarity and other tear function tests in patients with dry eye. Cömez AT; Tufan HA; Kocabıyık O; Gencer B Curr Eye Res; 2013 Nov; 38(11):1095-103. PubMed ID: 23841565 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]